feed,title,long_url,short_url
MarketWatch,"Gilead’s stock has fallen 21% since April 30, underscoring investor questions about remdesivir’s potential",http://www.marketwatch.com/news/story.asp?guid=%7B800147DA-EBB6-11EA-AE05-A3A40A80F382%7D&siteid=rss&rss=1,https://j.mp/2YQXdyC
